Editorial: Pharmacological impact of snake venom compounds

Current Pharmaceutical Design

Volumn 13, Issue 28, 2007, Pages 2851-2852

  Marcinkiewicz, Cezary ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTITHROMBOCYTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; COBROTOXIN; DISINTEGRIN; EPTIFIBATIDE; LECTIN; METALLOPROTEINASE; NEUROTOXIN; PHOSPHOLIPASE; SERINE PROTEINASE; SNAKE VENOM; SNAKE VENOM ANTISERUM; TIROFIBAN; VERY LATE ACTIVATION ANTIGEN 1; VIPER VENOM;

ANTIANGIOGENIC ACTIVITY; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; DRUG DESIGN; DRUG ISOLATION; DRUG MECHANISM; DRUG RESEARCH; DRUG SYNTHESIS; EDITORIAL; ENZYME ACTIVITY; HEMOSTASIS; HUMAN; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PUBLIC HEALTH; SIGNAL TRANSDUCTION; SNAKEBITE; SOLID TUMOR; STRUCTURE ACTIVITY RELATION; THROMBOCYTE FUNCTION; TUMOR VASCULARIZATION; ANIMAL; BLOOD; VASCULAR DISEASE;

ANIMALS; HUMANS; SNAKE VENOMS; VASCULAR DISEASES;

EID: 38449123661     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207782023720     Document Type: Editorial

References (9)

1. 1 Integrin. Curr Pharm Des 2007; 13(28): 2853-2859.
2. Swenson S, Ramu S, Markland FS. Anti-Angiogenesis and RGD-Containing Snake Venom Disintegrins. Curr Pharm Des 2007; 13(28): 2860-2871.
3. Yamazaki Y, Morita T. Snake Venom Components Affecting Blood Coagulation and the Vascular System: Structural Similarities and Marked Diversity. Curr Pharm Des 2007; 13(28): 2872-2886.
4. Clemetson KJ, Lu Q, Clemetson JM. Snake Venom Proteins Affecting Platelets and Their Applications to Anti-Thrombotic Research. Curr Pharm Des 2007; 13(28): 2887-2892.
5. Moura-da-Silva AM, Butera D, Tanjoni I. Importance of Snake Venom Metalloproteinases in Cell Biology: Effects on Platelets, Inflammatory and Endothelial Cells. Curr Pharm Des 2007; 13(28): 2893-2905.
6. Utkin YN, Osipov AV. Non-Lethal Polypeptide Components in Cobra Venom. Curr Pharm Des 2007; 13(28): 2906-2915.
7. Vogel C-W, Fritzinger DC. Humanized Cobra Venom Factor: Experimental Therapeutics for Targeted Complement Activation and Complement Depletion. Curr Pharm Des 2007; 13(28): 2916-2926.
8. Fox JW, Serrano SMT. Approaching the Golden Age of Natural Product Pharmaceuticals from Venom Libraries: An Overview of Toxins and Toxin-Derivatives Currently Involved in Therapeutic or Diagnostic Applications. Curr Pharm Des 2007; 13(28): 2927-2934.
9. Gutiérrez JM, Lomonte B, León G, Rucavado A, Chaves F, Angulo Y. Trends in Snakebite Envenomation Therapy: Scientific, Technological and Public Health Considerations. Curr Pharm Des 2007; 13(28): 2935-2950.